Illinois Oncology Research Association Community Clinical Oncology Program

伊利诺伊州肿瘤研究协会的长期目标 总部设在伊利诺伊州皮奥里亚的社区临床肿瘤学计划(IORA CCOP)基本保持不变 它继续在社区环境中工作，以加快制定干预措施 预防、治疗、康复和治愈癌症。具体地说，IORA CCOP寻求扩大 在伊利诺伊州中部和西部社区进行癌症临床试验；刺激优质护理 通过参与和采纳临床研究试验的结果，在整个社区范围内； 促进科学上可行的社区癌症网络的持续增长，以与NCI合作- 赞助合作团体试验；通过教育健康促进癌症预防、控制和治疗 护理专业人员和公众对癌症预防、早期发现和适当治疗的重要性 和持续护理，并让初级保健医生和其他专家参与癌症预防 尽可能地进行试验；增加已知和新的癌症治疗方法的知识库；并鼓励 少数群体和服务不足的人群参与癌症临床试验和相关研究。 IORA CCOP及其附属机构提供在18个县的集水区进行癌症临床试验的机会。 这一地区覆盖了超过12000平方英里的土地，其中大部分是农村地区，但大多数患者很容易在一个 距离IORA CCOP在16个社区的25个组件/附属机构之一一个小时的车程。虽然有6个 附属机构在皮奥里亚本身，IORA CCOP医学肿瘤学家旅行到所有15个社区以外 皮奥里亚周刊和所有社区都得到该区域附属辐射设施的支持。 IORA CCOP直接从北中癌症中心使用最先进的研究方案 治疗组(NCCTG)、东方合作肿瘤组(ECOG)、癌症和白血病B组 (CALGB)、国家外科辅助乳肠计划(NSABP)和放射治疗肿瘤学 小组(RTOG)，以及通过临床试验支助股(CTSU)与其他研究小组间接合作 在美国和加拿大。IORA CCOP与以下机构建立了良好的工作关系 组。其集中的记录保存和质量控制系统，其多年的临床试验经验， 其工作人员的专业知识，CCOP肿瘤学团队的承诺，以及 研究患者倡导者都愿意在一个社区进行持续的高质量研究 设定并产生患者利益和记录的结果。 相关性(见说明)：作为美国的类人猿，癌症继续对人们的生活产生重大影响 它的公民。由于大多数癌症患者是在他们的家乡社区接受治疗的，因此至关重要的是 为了癌症患者及其家人的公共健康，必须在当地提供高质量的癌症护理。癌 临床试验提供最好的癌症预防、治疗和症状管理，以及社区 临床肿瘤学计划是使这些最佳治疗方法在 并因此对所有癌症患者的治疗产生积极影响，即使是那些 没有参加临床试验。

The long-term objectives of the Illinois Oncology Research Association Community Clinical Oncology Program (IORA CCOP), based in Peoria, IL, remain essentially unchanged as it continues to work within a community setting to accelerate the development of interventions for preventing, treating, recovering from and curing cancer. Specifically, the IORA CCOP seeks to expand accrual to cancer clinical trials in the communities of central and western Illinois; stimulate quality care throughout the community through participation in and adoption of results from clinical research trials; promote the continued growth of a scientifically viable community cancer network to work with NCI- sponsored cooperative group trials; promote cancer prevention, control, and treatment by educating health care professionals and the public on the importance of cancer prevention, early detection, proper treatment and continuing care and by involving primary care physicians and other specialists in cancer prevention trials whenever possible; add to the knowledge base of known and new cancer treatments; and encourage the involvement of minority and underserved populations in cancer clinical trials and associated research. The IORA CCOP and its affiliates offer access to cancer clinical trials in an 18-county catchment area. This area spans more than 12,000 square miles of mostly rural country, yet most patients are easily within a one hour drive of one of the IORA CCOP's 25 components/affiliates in 16 communities. Although 6 of the affiliates are in Peoria itself, the IORA CCOP medical oncologists travel to all 15 communities outside Peoria weekly and all communities are supported by the affiliated radiation facilities in the region. The IORA CCOP uses state-of-the-art research protocols directly from the North Central Cancer Treatment Group (NCCTG), Eastern Cooperative Oncology Group (ECOG), Cancer and Leukemia Group B (CALGB), National Surgical Adjuvant Breast and Bowel Project (NSABP), and Radiation Therapy Oncology Group (RTOG), and indirectly, through the Clinical Trials Support Unit (CTSU), with other research groups in the United States and Canada. The IORA CCOP enjoys excellent working relationships with these groups. Its centralized record keeping and quality control systems, its years of clinical trials experience, the expertise of its staff, the commitment of the CCOP oncology team, and the active involvement of the research patient advocates all lend themselves to continued quality research conducted in a community setting and resulting in patient benefit and documented results. RELEVANCE (See instructions): As the U.S. DODulation apes, cancer continues to have a maior impact on the lives of its citizens. Since most cancer patients are treated in their home communities, it is critically important to the public health of cancer patients and their families that quality cancer care be available locally. Cancer clinical trials offer the best in cancer prevention, treatment and symptom management, and the Community Clinical Oncology Program is the ideal mechanism for making these best treatments available in the community and consequently having a positive impact on the treatments of all cancer patients, even those not participating in a clinical trial.